Black Diamond Therapeutics, Inc. (BDTX) ownership: Top institutional holder: T. Rowe Price Investment Management, Inc. ($22.50M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10563103.00 | $22.50M | 2026-03-31 |
| NEA Management Company, LLC | 4448757.00 | $9.48M | 2026-03-31 |
| VANGUARD GROUP INC | 2188857.00 | $5.32M | 2025-12-31 |
| ACADIAN ASSET MANAGEMENT LLC | 2348651.00 | $5.00M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1850468.00 | $3.94M | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1643747.00 | $3.50M | 2026-03-31 |
| DIMENSIONAL FUND ADVISORS LP | 1301664.00 | $2.77M | 2026-03-31 |
| Siren, L.L.C. | 1046517.00 | $2.54M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-03-20 | |
| Sell | null | 2026-03-20 | |
| Sell | null | 2026-01-21 | |
| Sell | null | 2026-01-21 | |
| Sell | null | 2026-01-21 | |
| Sell | null | 2026-01-21 | |
| Sell | null | 2026-01-21 | |
| Sell | null | 2025-12-12 |
Back to BDTX overview · BDTX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.